A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer

M. Elvington, Y.X. Huang, B.P. Morgan, F. Qiao, N. van Rooijen, C. Atkinson, S. Tomlinson

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)6043-6051
JournalBlood
Volume119
Issue number25
DOIs
Publication statusPublished - 2012

Cite this

Elvington, M., Huang, Y. X., Morgan, B. P., Qiao, F., van Rooijen, N., Atkinson, C., & Tomlinson, S. (2012). A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer. Blood, 119(25), 6043-6051. https://doi.org/10.1182/blood-2011-10-383232
Elvington, M. ; Huang, Y.X. ; Morgan, B.P. ; Qiao, F. ; van Rooijen, N. ; Atkinson, C. ; Tomlinson, S. / A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer. In: Blood. 2012 ; Vol. 119, No. 25. pp. 6043-6051.
@article{7672e6d8203a439f97d7fceeeca8a448,
title = "A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer",
author = "M. Elvington and Y.X. Huang and B.P. Morgan and F. Qiao and {van Rooijen}, N. and C. Atkinson and S. Tomlinson",
year = "2012",
doi = "10.1182/blood-2011-10-383232",
language = "Undefined/Unknown",
volume = "119",
pages = "6043--6051",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "25",

}

Elvington, M, Huang, YX, Morgan, BP, Qiao, F, van Rooijen, N, Atkinson, C & Tomlinson, S 2012, 'A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer' Blood, vol. 119, no. 25, pp. 6043-6051. https://doi.org/10.1182/blood-2011-10-383232

A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer. / Elvington, M.; Huang, Y.X.; Morgan, B.P.; Qiao, F.; van Rooijen, N.; Atkinson, C.; Tomlinson, S.

In: Blood, Vol. 119, No. 25, 2012, p. 6043-6051.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer

AU - Elvington, M.

AU - Huang, Y.X.

AU - Morgan, B.P.

AU - Qiao, F.

AU - van Rooijen, N.

AU - Atkinson, C.

AU - Tomlinson, S.

PY - 2012

Y1 - 2012

U2 - 10.1182/blood-2011-10-383232

DO - 10.1182/blood-2011-10-383232

M3 - Article

VL - 119

SP - 6043

EP - 6051

JO - Blood

JF - Blood

SN - 0006-4971

IS - 25

ER -